Low Endotoxin Recovery/Masking
Im Auftrag der European Compliance Academy

13-14 December 2016

Munich/Bernried, Germany

Seminar Nr. 15888

Unser Seminarservice

Kosten

Die Veranstaltung hat bereits stattgefunden

Rückfragen unter:
Tel.: 06221 / 84 44 0 E-Mail: info@concept-heidelberg.de

Sprecher

Dr. Ingo Ciolkowski, Lonza AG

John Dubczak, General Manager at Charles River

Stefan Gärtner, L+S AG

Dr Holger Grallert, Hyglos GmbH

Thomas Potrawfke, Haemochrom Diagnostica

Johannes Reich, University of Regensburg

Dr Friedrich von Wintzingerode, Roche Diagnostics GmbH

Zielsetzung

How to identify Low Endotoxin Recovery (LER)
How to Set-up hold-time studies
Analysis of influencing factors (Sample matrices, endotoxin, temperature, detection methods, etc.)
Understanding the driving forces of LER
Interpretation of test results
Dedicated sample treatment for demasking

Hintergrund

In the last years the LAL test has become the preferred system to test for endotoxins – for the in-process control as well as in the final inspection – and it is anchored in the pharmacopoeias. However, in the recent past, the problem of low endotoxin recovery employs the pharmaceutical microbiology. Masking – or not? Evidence gaps? And how can I close them? And how to evaluate?

These are the questions the pharmaceutical microbiologists as well as those responsible for the release have to deal with.

And last but not least, how can we handle the test in daily business in a practical manner.

Zielgruppe

Laboratory management and staff of pharmaceutical microbiology
Microbiologists and laboratory assistants from contract laboratories
Scientific staff from the area Endotoxin testing

Programm

Endotoxin Detection Methods I Definition of Endotoxins

Nature of Endotoxin
General detection methods

Endotoxin Detection Methods II

Basic reaction of Limulus-based detection methods
Sample handling
Construction and interpretation of standard curve

LER: Reflecting on Biopharmaceutical Operational Reality

Mechanisms of LER can be influenced by LPS stability
Varying size and fragility of LPS aggregates can be directly correlated to presence of chelating agents and detergents
Elucidating conformational changes, in real time, on LPS using HSAFM

Test Interference

Postitive Product Control (PPC)
Test inhibition
Test enhancement

Endotoxin Recovery Studies for the Detection of Endotoxin Masking Effects

Endotoxin Masking
Planning and implementation of hold-time studies
Interpretation of hold-time studies

Demasking of Endotoxin

Mechanistic principles of demasking
Development of demasking protocols
Implementation of demasking protocols

Sample Preparation for Demasking

Practical demasking procedure
Preparation of reagents for demasking
Application of demasking protocols

Round Table Discussion

Practical Laboratory Work - (Microcoat GmbH)

Simulation of contamination in various sample matrices

Preparation of samples affected by
Test interference
Sample interference

Endotoxin Service Team, Microcoat GmbH

Analysis of interference in affected samples

Application of different detection systems
Limulus Amebocyte Lysate assay
Recombinant Factor C assay

Endotoxin Service Team, Microcoat GmbH

Sample treatment for demasking

Screening for demasking protocol
Optimization of demasking protocol
Evaluation of demasking protocol

Endotoxin Service Team, Microcoat GmbH

Interpretation and Comparison of Results

Differentiation between test and sample interference
Effects of different detection systems
Demasking of endotoxin

Endotoxin Service Team, Microcoat GmbH

Closing Remarks (ECA Academy)

Zurück

Low Endotoxin Recovery/MaskingIm Auftrag der European Compliance Academy